Mammographic screening detects low-risk tumor biology breast cancers

di Drukker, C. A., Schmidt, M. K., Rutgers, E. J. T., Cardoso, F., Kerlikowske, K., Esserman, L. J., van Leeuwen, F. E., Pijnappel, R. M., Slaets, L., Bogaerts, J., van’t Veer, L. J.
Pubblicazione 2014

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

di Viale, G., Slaets, L., Bogaerts, J., Rutgers, E., van't Veer, L., Piccart-Gebhart, M. J., de Snoo, F. A., Stork-Sloots, L., Russo, L., Dell'Orto, P., van den Akker, J., Glas, A., Cardoso, F.
Pubblicazione 2014

Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised...

di Bonnefoi, H., Jacot, W., Saghatchian, M., Moldovan, C., Venat-Bouvet, L., Zaman, K., Matos, E., Petit, T., Bodmer, A., Quenel-Tueux, N., Chakiba, C., Vuylsteke, P., Jerusalem, G., Brain, E., Tredan, O., Messina, C. G. M., Slaets, L., Cameron, D.
Pubblicato in Ann Oncol (2015)

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

di Cardoso, F, Bartlett, J M S, Slaets, L, van Deurzen, C H M, van Leeuwen-Stok, E, Porter, P, Linderholm, B, Hedenfalk, I, Schröder, C, Martens, J, Bayani, J, van Asperen, C, Murray, M, Hudis, C, Middleton, L, Vermeij, J, Punie, K, Fraser, J, Nowaczyk, M, Rubio, I T, Aebi, S, Kelly, C, Ruddy, K J, Winer, E, Nilsson, C, Dal Lago, L, Korde, L, Benstead, K, Bogler, O, Goulioti, T, Peric, A, Litière, S, Aalders, K C, Poncet, C, Tryfonidis, K, Giordano, S H
Pubblicato in Ann Oncol (2018)